Log In
Friday 22nd June 2018

NICE backing for combi inhalers

4th April 2008

New guidance from the National Institute for Health and Clinical Excellence (NICE) has approved combination inhalers for patients with chronic asthma.

It says that for adults and children over the age of 12, who require both an inhaled corticosteroid (ICS) and a long-acting beta-2 agonist (LABA), a combination device should be considered to deliver the drugs. The guidance recommends GPs choose between combination treatment and separate devices, depending on therapeutic need or how likely the patient is to adhere to the treatment.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018